Most, if not all of the nootropics out there are so-called "small molecule" drugs; their relatively simple molecular structure lends itself to easy synthesis (but wide-ranging, unpredictable effects within the human body).
Pharmaceuticals (and hopefully nootropics) in general are progressing toward more "large molecule" medicines (or "biologics" as this informative page on Bayer's site terms) that are much harder to design and manufacture, but have a more directed/precise effect within the human body.
Most, if not all of the nootropics out there are so-called "small molecule" drugs; their relatively simple molecular structure lends itself to easy synthesis (but wide-ranging, unpredictable effects within the human body).
Pharmaceuticals (and hopefully nootropics) in general are progressing toward more "large molecule" medicines (or "biologics" as this informative page on Bayer's site terms) that are much harder to design and manufacture, but have a more directed/precise effect within the human body.
All of the top "new&qu... (read more)